c4c (conect4children) is a large collaborative European network that aims to facilitate the development of new drugs and other therapies for the entire paediatric population. The project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777389.

The Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.


c4c Network Vision

Better medicines for babies, children and young people through a pan-European clinical trial network.


c4c Network Mission

c4c will use a coordinated approach to deliver high quality “regulatory grade” clinical trials in:

  • Multiple countries

  • Multiple sites

  • All paediatric age groups

by supporting:

  • Trial implementation using resources shared between studies

  • Trial design through a combination of information about natural history, feasibility, appropriate innovation, and expert opinion

  • Education and awareness within and beyond the network.


The founder members of eYPAGnet are participating in c4c project in the activities regarding the patients involvement as a cross-cutting theme that will ensure the patient centricity of the c4c network.


Link to the official website: www.conect4children.org